Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
matheswaran.kandasamy@rdm.ox.ac.uk

Research groups

Clarke Group | Metabolism and Immunity

Matheswaran Kandasamy

Postdoctoral Scientist

Recent publications

Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors.
Journal article

Kandasamy M. et al, (2023), Elife, 12
Recombinant single-cycle influenza virus as a new tool to augment antitumour immunity with immune checkpoint inhibitors
Preprint

Kandasamy M. et al, (2021)
Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide.
Journal article

Shenderov E. et al, (2021), J immunother cancer, 9
Suppression of Cytotoxic T Cell Functions and Decreased Levels of Tissue-Resident Memory T Cells during H5N1 Infection.
Journal article

Kandasamy M. et al, (2020), J virol, 94
Sterile activation of invariant natural killer T cells by ER-stressed antigen-presenting cells.
Journal article

Bedard M. et al, (2019), Proc natl acad sci u s a, 116, 23671 - 23681

More publications